India: Second National Tuberculosis Control Project

Abstract*

The Second National Tuberculosis Control Program Project for India aims (1) to achieve the global targets of 70 percent case detection and 85 percent cure rate in 100 percent of the districts; and (2) in those the zones where Directly Observed Treatment, short course (DOTS) has been under implementation for five or more years, to cause the incidence of smear-positive Tuberculosis (TB) to start to decline. There are two project components. Component... Show More

Development Objective

(i) to achieve the global targets of 70% case detection and 85% cure rate in 100% of the districts; and (ii) for the zones where DOTS has been under implementation for five or more years, the incidence of smear-positive TB starts to decline.

Key Details

Project Details

Project ID
P078539
Status
Closed
Team Leader
Patrick Mullen
Borrower 2
N/A

Country
India
Disclosure Date
February 14, 2005
Approval Date
(as of board presentation)
August 22, 2006
Effective Date
November 22, 2006

Total Project Cost 1
US$ 212.50 million
Implementing Agency
N/A
Region
South Asia
Fiscal Year 3
2007

Commitment Amount
US$ 170.00 million
Environmental Category
B
Environmental and Social Risk
Not Applicable
Closing Date
September 30, 2012

Last Stage Reached
BANK APPROVED
Last Update Date
February 14, 2013

Associated Projects
P118832

Notes
1. Total project cost includes funding from World Bank and non-bank sources in US$ millions. Active and Closed projects show current commitments. Proposed (pipeline) and dropped projects show the forecast amount. The commitment amount for projects in the pipeline is indicative and may be modified during the project preparation.
2. Borrower refers to the Borrower of a Loan or Recipient of a Grant.
3. ”Fiscal Year” is the fiscal year in which the project was approved (or dropped if the status is dropped). The World Bank's fiscal year is from July 1 - June 30. For example, a fiscal year of 1996 corresponds to July 1, 1995 - June 30, 1996.

Sectors

Themes

FY17 - Human Development and Gender

FY17 - Disease Control50%
- FY17 - HIV/AIDS17%
- FY17 - Tuberculosis33%
FY17 - Health Systems and Policies33%
- FY17 - Health System Strengthening33%

FY17 - Public Sector Management

FY17 - Public Administration17%
- FY17 - Municipal Institution Building17%

Project Map

Interactive Map

Finances

Financing Plan (US$ Millions)

Financier	Commitments
IDA Credit	170.00
Borrower/Recipient	42.50

Total Project Financing (US$ Millions)

Product Line	IBRD/IDA
IBRD Commitment	N/A
IDA Commitment	170.00
IBRD + IDA Commitment	170.00

Lending Instrument
Grant Amount	N/A
Total Project Cost**	212.50

Summary Status of World Bank Financing (US$ Millions) as of April 30, 2025

No data available.

Detailed Financial Activity as of April 30, 2025

Download:

Period	Financier	Transaction Type	Amount (US$)
Feb 15, 2014	IDA-42280	Int Charges	2,720.35
Feb 15, 2014	IDA-42280	Int Charges	2,720.35
Aug 15, 2015	IDA-42280	Loan Repay	152,146.81
Aug 15, 2015	IDA-42280	Loan Repay	3,907,808.20
Aug 15, 2015	IDA-42280	Int Charges	578,543.60
Aug 15, 2015	IDA-42280	Int Charges	578,543.60
Aug 15, 2016	IDA-42280	Int Charges	39,204.42
Aug 15, 2016	IDA-42280	Int Charges	39,204.42
Feb 15, 2016	IDA-42280	Loan Repay	2,511.50
Feb 15, 2016	IDA-42280	Loan Repay	4,063,749.20
Feb 15, 2016	IDA-42280	Int Charges	524,701.30
Feb 15, 2016	IDA-42280	Int Charges	524,701.30
Aug 15, 2017	IDA-42280	Int Charges	436,345.72
Aug 15, 2017	IDA-42280	Int Charges	436,345.72
Aug 15, 2017	IDA-42280	Int Charges	34,556.82
Aug 15, 2017	IDA-42280	Int Charges	34,556.82
Aug 15, 2017	IDA-42280	Loan Repay	4,070,715.00
Feb 15, 2017	IDA-42280	Loan Repay	3,869,314.80
Feb 15, 2017	IDA-42280	Int Charges	479,325.22
Feb 15, 2017	IDA-42280	Int Charges	479,325.22
Feb 15, 2017	IDA-42280	Loan Repay	35,229.25
Aug 15, 2016	IDA-42280	Loan Repay	4,036,613.00
Aug 15, 2016	IDA-42280	Int Charges	544,942.75
Aug 15, 2016	IDA-42280	Int Charges	544,942.75
Aug 15, 2018	IDA-42280	Loan Repay	4,001,354.20
Aug 15, 2018	IDA-42280	Int Charges	480,162.47
Aug 15, 2018	IDA-42280	Int Charges	480,162.47
Aug 15, 2018	IDA-42280	Int Charges	139,757.36
Aug 15, 2018	IDA-42280	Int Charges	139,757.36
Feb 15, 2018	IDA-42280	Int Charges	374,732.72
Feb 15, 2018	IDA-42280	Int Charges	374,732.72
Feb 15, 2018	IDA-42280	Int Charges	85,679.78
Feb 15, 2018	IDA-42280	Int Charges	85,679.78
Feb 15, 2018	IDA-42280	Loan Repay	4,218,895.00
Aug 15, 2019	IDA-42280	Loan Repay	3,975,351.00
Aug 15, 2019	IDA-42280	Int Charges	447,227.00
Aug 15, 2019	IDA-42280	Int Charges	447,227.00
Feb 15, 2019	IDA-42280	Loan Repay	3,918,147.50
Feb 15, 2019	IDA-42280	Int Charges	441,756.56
Aug 15, 2022	IDA-42280	Int Charges	372,367.97
Aug 15, 2022	IDA-42280	Int Charges	372,367.97
Feb 15, 2022	IDA-42280	Int Charges	395,198.44
Feb 15, 2022	IDA-42280	Int Charges	395,198.44
Feb 15, 2022	IDA-42280	Loan Repay	1,993,134.10
Feb 15, 2022	IDA-42280	Loan Repay	32,794.06
Aug 15, 2023	IDA-42280	Int Charges	346,837.70
Aug 15, 2023	IDA-42280	Int Charges	20,706.77
Aug 15, 2023	IDA-42280	Loan Repay	3,853,752.50
Aug 15, 2023	IDA-42280	Int Charges	20,706.77
Aug 15, 2023	IDA-42280	Int Charges	346,837.70
Feb 15, 2023	IDA-42280	Int Charges	341,868.30
Feb 15, 2023	IDA-42280	Loan Repay	36,344.92
Feb 15, 2023	IDA-42280	Loan Repay	3,831,956.80
Feb 15, 2023	IDA-42280	Int Charges	341,868.30
Aug 22, 2006	IDA-42280	Loan Commitment	170,000,000.00
Feb 15, 2024	IDA-42280	Loan Repay	7,223.73
Feb 15, 2024	IDA-42280	Loan Repay	3,818,963.80
Feb 15, 2024	IDA-42280	Int Charges	330,008.62
Feb 15, 2024	IDA-42280	Int Charges	330,008.62
Aug 15, 2024	IDA-42280	Int Charges	193,226.02
Aug 15, 2024	IDA-42280	Int Charges	193,226.02
Aug 15, 2024	IDA-42280	Loan Repay	56,460.32
Aug 15, 2024	IDA-42280	Loan Repay	7,687,027.00
Aug 15, 2013	IDA-42280	Int Charges	3,646.23
Aug 15, 2013	IDA-42280	Int Charges	3,646.23
Aug 15, 2013	IDA-42280	Int Charges	655,029.20
Aug 15, 2013	IDA-42280	Int Charges	655,029.20
Aug 15, 2014	IDA-42280	Int Charges	663,404.56
Aug 15, 2014	IDA-42280	Int Charges	663,404.56
Aug 15, 2014	IDA-42280	Int Charges	2,680.93
Aug 15, 2014	IDA-42280	Int Charges	2,680.93
Aug 15, 2014	IDA-42280	Loan Repay	4,422,697.00
Feb 15, 2015	IDA-42280	Loan Repay	34,844.88
Feb 15, 2015	IDA-42280	Int Charges	598,785.44
Feb 15, 2015	IDA-42280	Int Charges	598,785.44
Feb 15, 2015	IDA-42280	Loan Repay	4,059,414.80
Feb 15, 2014	IDA-42280	Int Charges	664,510.90
Feb 15, 2014	IDA-42280	Int Charges	664,510.90
Feb 15, 2019	IDA-42280	Int Charges	441,756.56
Feb 15, 2019	IDA-42280	Loan Repay	92,433.50
Feb 15, 2020	IDA-42280	Loan Repay	3,926,525.80
Feb 15, 2020	IDA-42280	Loan Repay	28,925.35
Feb 15, 2020	IDA-42280	Int Charges	430,155.30
Feb 15, 2020	IDA-42280	Int Charges	430,155.30
Aug 15, 2019	IDA-42280	Int Charges	24,258.52
Aug 15, 2019	IDA-42280	Int Charges	24,258.52
Feb 15, 2021	IDA-42280	Loan Repay	1,862,315.00
Feb 15, 2021	IDA-42280	Int Charges	424,815.60
Feb 15, 2021	IDA-42280	Int Charges	424,815.60
Feb 15, 2021	IDA-42280	Int Charges	54,245.22
Feb 15, 2021	IDA-42280	Int Charges	54,245.22
Feb 15, 2021	IDA-42280	Loan Repay	221,331.98
Aug 15, 2020	IDA-42280	Loan Repay	53,172.09
Aug 15, 2020	IDA-42280	Loan Repay	1,985,540.60
Aug 15, 2020	IDA-42280	Int Charges	0.01
Aug 15, 2020	IDA-42280	Int Charges	0.01
Aug 15, 2020	IDA-42280	Int Charges	375,054.28
Aug 15, 2020	IDA-42280	Int Charges	375,054.28
Aug 15, 2021	IDA-42280	Int Charges	4,866.67
Aug 15, 2021	IDA-42280	Int Charges	4,866.67
Aug 15, 2021	IDA-42280	Loan Repay	2,054,144.00
Aug 15, 2021	IDA-42280	Int Charges	37,542.09
Aug 15, 2021	IDA-42280	Int Charges	37,542.09
Aug 15, 2021	IDA-42280	Int Charges	378,422.03
Aug 15, 2021	IDA-42280	Int Charges	378,422.03
Aug 15, 2022	IDA-42280	Loan Repay	3,819,159.00
Aug 15, 2022	IDA-42280	Int Charges	7,026.61
Aug 15, 2022	IDA-42280	Int Charges	7,026.61

Footnotes

Ratings

IMPLEMENTATION RATINGS

Name	Review	Date
Procurement	Moderately Satisfactory	2012-11-27
Financial Management	Moderately Satisfactory	2012-11-27
Project Management	Satisfactory	2012-11-27
Monitoring and Evaluation	Highly Satisfactory	2012-11-27
Progress towards achievement of PDO	Satisfactory	2012-11-27
Counterpart Funding	Highly Satisfactory	2012-11-27
Overall Implementation Progress (IP)	Satisfactory	2012-11-27

COMPLETION RATINGS

INDICATOR	IMPLEMENTATION COMPLETION & RESULTS REPORT: 04-29-2013
Outcomes	Substantial
Risk to Development Outcome	Negligible
Bank Performance	Substantial
Borrower Performance	Substantial
Government Performance	Substantial
Implementing Agency	Substantial

INDEPENDENT EVALUATION RATINGS

INDICATOR	ICR REVIEW: 10-02-2013	PROJECT PERFORMANCE ASSESSMENT REPORT:
Outcome Rating	Satisfactory	N/a
Risk To Development Outcome	Negligible To Low	N/a
Bank Performance	Satisfactory	N/a
Borrower Performance	Moderately Satisfactory	N/a
Government Performance	Satisfactory	N/a
Implementing Agency	Moderately Satisfactory	N/a
Icr Quality	Satisfactory	N/a
M&e Quality	Substantial	N/a

Results Framework

PROJECT DEVELOPMENT OBJECTIVE INDICATORS

INDICATOR		BASELINE	CURRENT	TARGET

Number of districts which have reached the global targets for cure rate and case detection rate.	Value	111	249	450
	Date	June 30, 2006	March 31, 2012	March 31, 2012
	Comment		The denominator for the case detection rate (disease incidence) is not estimated at the district level, but at the zonal level(groups of states). Nevertheless, the program monitors this indicator, and in the last quarter of 2011, 249 districts exceeded both70% case detection and 85% treatment success. 314 districts exceeded the case detection target, while 499 districts exceeded thetreatment success target. Alternatively, the national case detection target is >70% and treatment success target is >85%, and theprogram has met these targets for the last several years (in 2011, 79% case detection & 85.1% treatment success).

Incidence (ARTI) for zones where DOTS has been implemented 5 years or more. Value 1.5% 1.1% 1.34%
Date June 30, 2006 September 30, 2011 March 31, 2012
Comment

People receiving tuberculosis treatment in accordance with the WHO-recommended “Directly Observed Treatment Strategy” (DOTS) (number)	Value	0.00	7563296.00	0.00
	Date	November 22, 2006	December 31, 2011
	Comment		cumulative of:- 2007: 1,474,605- 2008: 1,517,363- 2009: 1,533,309- 2010: 1,522,147- 2011: 1,515,872

INTERMEDIATE RESULTS INDICATORS

INDICATOR		BASELINE	CURRENT	TARGET

Number of states which have reached the global targets for cure rate and case detection rate. Value 8 29 28
Date June 30, 2006 March 31, 2012 March 31, 2012
Comment

Average case detection rate and cure rate in 139 poor and backward districts.	Value	Case detection rate: 59% Cure rate: 86%	Case detection rate: 61%Treatment success rate: 8	Case detection rate: > 70% Cure rate: >85%
	Date	June 30, 2006	March 31, 2012	March 31, 2012
	Comment

Percentage of patients on DOTS under 15 years of age (out of total patients on DOTS) Value 6% 7% 7%
Date June 30, 2006 March 31, 2012 March 31, 2012
Comment
Number of persons referred from VCT that are diagnosed with TB and placed on DOTS. Value 7664 42,783 Increasing trend.
Date December 30, 2006 March 31, 2012 March 31, 2012
Comment
TB suspects examined per 100,000 population Value 138 164 increasing trend
Date December 31, 2007 March 31, 2012 March 31, 2012
Comment
Number of MDR-TB cases started on DOTS Plus treatment Value 0.00 12100.00 2350.00
Date December 31, 2006 June 30, 2012 March 31, 2012
Comment cumulative since the start of MDR-TB services
Number of paediatric cases (under 15 years) receiving DOTS Value 64697.00 84059.00 0.00
Date December 31, 2006 March 31, 2012
Comment
Number of quality-assured labs available to undertake DST under RNTCP Value 0.00 42.00 24.00
Date December 31, 2006 June 30, 2012 March 31, 2012
Comment
Number of DOTS Plus sites initiated Value 0.00 435.00 21.00
Date December 31, 2006 June 30, 2012 March 31, 2012
Comment MDR-TB services are available in 435 districts

Incidence (ARTI) for zones where DOTS has been implemented 5 years or more.	Value	1.5%	1.1%	1.34%
	Date	June 30, 2006	September 30, 2011	March 31, 2012
	Comment

Number of persons referred from VCT that are diagnosed with TB and placed on DOTS.	Value	7664	42,783	Increasing trend.
	Date	December 30, 2006	March 31, 2012	March 31, 2012
	Comment

TB suspects examined per 100,000 population	Value	138	164	increasing trend
	Date	December 31, 2007	March 31, 2012	March 31, 2012
	Comment

Number of paediatric cases (under 15 years) receiving DOTS	Value	64697.00	84059.00	0.00
	Date	December 31, 2006	March 31, 2012
	Comment

Number of DOTS Plus sites initiated	Value	0.00	435.00	21.00
	Date	December 31, 2006	June 30, 2012	March 31, 2012
	Comment		MDR-TB services are available in 435 districts